Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

Also known as: Nodular Lymphocyte-Predominant Hodgkin Lymphoma / Nodular Lymphocyte Predominant Hodgkin Lymphoma / Hodgkin lymphoma, nodular lymphocyte predominance (disorder) / Hodgkin lymphoma, nodular lymphocyte predominance (morphologic abnormality) / Lymphocyte-rich Hodgkin lymphoma / Hodgkin's disease, lymphocytic-histiocytic predominance / Hodgkin's disease lymphocyte predominance type stage unspecified / Lymphocyte-Rich Classical Hodgkin's Lymphoma / Hodgkin lymphoma, lymphocyte-rich (disorder) / Hodgkin lymphoma, lymphocyte-rich (morphologic abnormality)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09053Ibrutinib2Completed1
DB00073Rituximab2Completed1